FDA approves bosutinib for pediatric patients with chronic myelogenous
FDA approves bosutinib for pediatric patients with chronic myelogenous leukemia
Related Articles
FDA to Hold Listening Session as Part of Broader Work to Optimize Use of, and Processes for, Advisory Committees
FDA will host a listening session in June as part of broader work to optimize the use of, and processes, for advisory committees.
Search for FDA Guidance Documents
Search for official FDA guidance documents and other regulatory guidance for all topics
FDA updates warnings for fluoroquinolone antibiotics
FDA issued a safety warning that fluoroquinolone antibiotic use has been associated with aortic aneurysms and dissection of aortic aneurysms. Health care professionals should avoid…
Chuao Chocolatier Recalls Its: .39 oz /11 Gram Potato Chip Mini Bar Lot 4022 Due to Undeclared Hazelnuts
May 3, 2024, Chuao Chocolatier is voluntarily recalling a single production of Potato Chip mini bar .39oz/11 gram LOT 4022 because some packages may contain…
Asian Americans, Native Hawaiian, and Other Pacific Islanders
Asian Americans, Native Hawaiian, and Other Pacific Islanders
FDA alerts health care professionals of pregnancy problems associated
FDA is alerting health care professionals of the rare risk of intrahepatic cholestasis of pregnancy (ICP) associated with the use of thiopurines.
Project Facilitate
Assisting Healthcare Providers with Expanded Access Requests for Investigational Oncology Products